Skip to main content

Universe Pharmaceuticals INC

UPC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001809616

No open-market purchases or sales by Universe Pharmaceuticals INC insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $228.4K in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Universe Pharmaceuticals INC as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
+7 vs. Q2 2024
Shares held
691.5K
+685.9K (+12,388.2%) vs. Q2 2024
Total value
$168.5K
+$155.5K (+1,192.1%) vs. Q2 2024
New holders
8
1 more added
Sold out
1
0 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting UPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 9 institutions
Q1 2021: 4 institutionsQ2 2021: 3 institutionsQ3 2021: 5 institutionsQ4 2021: 5 institutionsQ1 2022: 4 institutionsQ2 2022: 4 institutionsQ3 2022: 3 institutionsQ4 2022: 3 institutionsQ1 2023: 2 institutionsQ2 2023: 4 institutionsQ3 2023: 2 institutionsQ4 2023: 1 institutionQ1 2024: 2 institutionsQ2 2024: 2 institutionsQ3 2024: 9 institutionsQ4 2024: 3 institutionsQ1 2025: 1 institutionQ2 2025: 0 institutionsQ3 2025: 2 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 4 institutions
Value heldQ3 2024: $168.5K
Q1 2021: $332.0KQ2 2021: $151.0KQ3 2021: $844.0KQ4 2021: $1.95MQ1 2022: $1.40MQ2 2022: $181.0KQ3 2022: $24.0KQ4 2022: $93.7KQ1 2023: $40.0KQ2 2023: $33.7KQ3 2023: $5.81KQ4 2023: $12.0KQ1 2024: $2.38KQ2 2024: $13.0KQ3 2024: $168.5KQ4 2024: $343.9KQ1 2025: $1.09KQ2 2025: $0Q3 2025: $9.04KQ4 2025: $3.60KQ1 2026: $0Q2 2026: $228.4K
Institutions holding UPC and their total value by quarter
QuarterHoldersValue
Q2 20264$228.4K
Q1 20260$0
Q4 20251$3.60K
Q3 20252$9.04K
Q2 20250$0
Q1 20251$1.09K
Q4 20243$343.9K
Q3 20249$168.5K
Q2 20242$13.0K
Q1 20242$2.38K
Q4 20231$12.0K
Q3 20232$5.81K
Q2 20234$33.7K
Q1 20232$40.0K
Q4 20223$93.7K
Q3 20223$24.0K
Q2 20224$181.0K
Q1 20224$1.40M
Q4 20215$1.95M
Q3 20215$844.0K
Q2 20213$151.0K
Q1 20214$332.0K

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Universe Pharmaceuticals INC; share changes are against Q2 2024.

Institutions holding UPC in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG242,460$59.2K0.00%+237,223+4,529.7%Added
MML Investors Services, LLC234,260$57.0K0.00%+234,260New
Two Sigma Securities, LLC90,371$22.1K0.00%+90,371New
Renaissance Technologies LLC39,267$9.58K0.00%+39,267New
Quadrature Capital Ltd24,891$6.06K0.00%+24,891New
Virtu Financial LLC16,585$4.00K0.00%+16,585New
StoneX Group Inc.15,008$3.66K0.00%+15,008New
XTX Topco Ltd14,820$3.62K0.00%+14,820New
Millennium Management LLC13,809$3.37K0.00%+13,809New
Acadian Asset Management LLC0$00.00%−300−100.0%Sold out